Person

David S. Wichmann

Director, Boston Scientific

Current S&P 500 boards
1
Current roles
1
Open-market buys
$5.7M
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 15, 2021BSXBuy25,000$41.98$1.0M
May 3, 2019UNHBuy20,000$231.79$4.6M

SEC reporting-owner ID (CIK) 1268489 · all filings on EDGAR